Allergy & Asthma Care of Florida Announces Rebrand to AllerVie Health and Launch of New Digital Patient Experience

December 07, 2023 01:00 AM AEDT | By EIN Presswire

Google News:

Recent News

James Hardie Industries plc Announces Successful Closing of Offering o...

Horizon Minerals Builds Momentum with Gold Cashflows Amid ASX200 Resou...

ASX Set to Open Lower as Middle East Tensions Shake Global Markets

NextDC Expands Financial Muscle with $2.2 Billion Debt Injection to Fu...

OCALA, FLORIDA, UNITED STATES, December 6, 2023 /EINPresswire.com/ -- Today, AllerVie Health, a leading provider of allergy and immunology services in the United States, announced that Allergy & Asthma Care of Florida will fully transition to the AllerVie Health brand in December. The rebranding coincides with the implementation of a new electronic medical record (EMR) system and cutting-edge digital patient experience, showcasing AllerVie's commitment to providing the highest quality care and patient-centric services.

"Our patients are at the heart of everything we do, and we are thrilled to embark on this transformative journey as AllerVie Health," said Carly Gollihar, Regional Director of Operations for Florida. "This rebrand and the new digital patient experience represent our unwavering dedication to advancing patient care, ensuring safety, efficiency, and convenience."

Under the AllerVie Health brand, the clinic continues its dedication to serving Florida while opening doors to expanded services, increased access to care, and incorporating the latest advances in allergy, asthma, immunology, and clinical research.

Additionally, integrating a new EMR system and patient portal will enhance communication, streamline processes, and provide a secure platform for patients to access their medical information conveniently. The new electronic features include:

• Health Records
• Secure Messaging
• Online Appointments
• Medication Management
• Bill Pay Options
• Forms and Documents

The providers at AllerVie Health's Ocala and The Villages locations, including Dr. Thomas Johnson, Beau Caruthers, Kristin Debusk, and Joshua Jurczak, are enthusiastic about the positive impact this transformation will have on advancing patient care and are strong advocates for this transformative journey.

Patients are encouraged to stay tuned for more details as the clinic embraces this exciting new chapter. For inquiries and more information, please contact the clinic directly or visit www.allervie.com/aacfinc/.

About AllerVie Health
AllerVie Health is a national network of board-certified allergists and immunologists partnering together for the advancement of patient care, serving patients across 12 states in 75 clinic locations. Our providers are committed to establishing the allergy and immunology gold standard, expanding access to best-in-class care, and bringing relief and renewed vitality to the millions of Americans affected annually, many of whom live in underserved communities today. AllerVie is relentlessly dedicated to clinical excellence, creating an improved patient experience, and supporting the development of advanced allergy and immunology-focused therapeutics and treatment options. With AllerVie Health, our patients can feel their best, reclaim their lives, and live in freedom! To learn more, visit www.allervie.com.

Rachel Russell
AllerVie Health
+1 817-253-2940
[email protected]

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.